Significant responses to platinum-based chemotherapy in renal medullary carcinoma.

Journal Article (Review)

Most patients with renal medullary carcinoma (RMC) have advanced disease at presentation and rarely respond to radiation or chemotherapy. We describe two adolescents with metastatic disease who had significant responses to cisplatin or carboplatin in combination with gemcitabine and paclitaxel.

Full Text

Duke Authors

Cited Authors

  • Strouse, JJ; Spevak, M; Mack, AK; Arceci, RJ; Small, D; Loeb, DM

Published Date

  • April 2005

Published In

Volume / Issue

  • 44 / 4

Start / End Page

  • 407 - 411

PubMed ID

  • 15602719

Pubmed Central ID

  • 15602719

International Standard Serial Number (ISSN)

  • 1545-5009

Digital Object Identifier (DOI)

  • 10.1002/pbc.20292


  • eng

Conference Location

  • United States